3.0.0 898 2023-02-07T14:30:36Z 2023-02-07T14:30:36Z Senate S 2021-03-23 117 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2021-03-23T17:14:46Z Lower Costs, More Cures Act of 2021 117 19 HR 2021-10-19 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. Related bill CRS Medicare for America Act of 2019 117 9655 HR 2022-12-21 Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, the Judiciary, Natural Resources, Education and Labor, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Related bill CRS 2021-03-23 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2021-03-23 Introduced in Senate IntroReferral 10000 9 Library of Congress B001230 Sen. Baldwin, Tammy [D-WI] Tammy Baldwin D WI N B001310 Sen. Braun, Mike [R-IN] Mike Braun R IN 2021-03-23 True S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN 2021-03-23 True M001153 Sen. Murkowski, Lisa [R-AK] Lisa Murkowski R AK 2021-03-23 True H001061 Sen. Hoeven, John [R-ND] John Hoeven R ND 2021-06-09 False K000383 Sen. King, Angus S., Jr. [I-ME] Angus King I ME S. 2021-06-09 False Health Business records Civil actions and liability Congressional oversight Consumer affairs Corporate finance and management Government information and archives Government studies and investigations Health care costs and insurance Inflation and prices Manufacturing Marketing and advertising Medical research Prescription drugs Research and development Health 00 2021-03-23 Introduced in Senate 2021-06-23T18:28:16Z Fair Accountability and Innovative Research Drug Pricing Act of 2021

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.

]]> Fair Accountability and Innovative Research Drug Pricing Act of 2021 Display Title Fair Accountability and Innovative Research Drug Pricing Act of 2021 Official Title as Introduced A bill to require reporting regarding certain drug price increases, and for other purposes. Introduced in Senate IS Short Title(s) as Introduced Fair Accountability and Innovative Research Drug Pricing Act of 2021 Introduced in Senate IS Introduced in Senate 2021-03-23T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-117s898is/xml/BILLS-117s898is.xml 2021-03-23 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.